Metastatic tumours in the sinonasal region are relatively rare, and the most frequent primary site is the kidney, followed by the lung, breast, urogenital tract, gastrointestinal tract and thyroid gland.^[@r1],[@r2]^ Extrahepatic metastasis of hepatocellular carcinoma (HCC) occurs in about 30--50% of patients and the most common sites are lung, lymph nodes, bone and adrenal gland.^[@r3]--[@r5]^ The sinonasal region, however, is an unusual site for metastatic HCC, and the most affected regions in order of decreasing frequency are the maxillary sinus, ethmoid bones and sphenoid bones.^[@r6]^ Metastases to the nasal cavity, including the nasal septum and turbinates, are even more rare; only 13 cases are reported in the literature ([Table 1](#t1){ref-type="table"}). These include eight patients with metastatic HCC involving the paranasal sinus and nasal cavity at presentation, four patients with involvement of the nasal septum or nasal vestibule, one patient with involvement of the nasal septum and nasal cavity, and three patients with involvement of only the nasal cavity. Herein, we present an additional case of rapidly growing metastatic HCC to the nasal cavity alone, with MRI scan and review of the reported cases.

###### 

Thirteen reported cases of biopsy-proven metastatic HCC to the sinonasal region

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  No             Sex/age (y)   Sx                             Carrier, risk factor   HCC dx to nasal sx   Extrahepatic mets       Involved site             Lung → SN mets    CT scan                             MRI scan   Tx                   Progrosis (after nasal mets)
  -------------- ------------- ------------------------------ ---------------------- -------------------- ----------------------- ------------------------- ----------------- ----------------------------------- ---------- -------------------- -----------------------------------------------------
  Frigy          M/61          Epistaxis                      Alcoholism             At presentation      Lung                    Ethmoid sinus,\           At presentation   No                                  No                              Died\
                                                                                                                                  nasal\                                                                                                          suddenly,\
                                                                                                                                  cavity                                                                                                          respiratory failure

  Patankar       M/50          Epistaxis, nasal obstruction   NA                     NA                   Not mentioned           Nasal cavity                                Mass                                No         Refused tx           NA

  English III    M/44          Epistaxis, facial pain         Hep C,\                NA                   Not mentioned           Nasal cavity                                Mass                                No         Chemo                Bone metas, new hepatic HCC (several m)
                                                              S/P LT                                                                                                                                                                              

  Lin            M/45          Septal mass                    Hep B                  2 y 3 m              Duodenum                septum                                      No                                  No         RTx                  Died, hepatic failure (6 w)

  Matsuda        M/71          Epistaxis                                             7 y                  Lung                    Maxillary sinus,\         6 m               Osteolysis of maxillary and orbit   No         RTx                  Died, hepatic failure (8 w)
                                                                                                                                  nasal\                                                                                                          
                                                                                                                                  cavity                                                                                                          

  Chang          M/49          Septal mass                    Hep B                  16 m                 Lung                    Septum                    16 m              Enhancing\                          No         RTx                  Aliver at 15 m follow-up
                                                                                                                                                                              tumour                                                              

  Kurisu         M/76          Nasal obstruction              Hep C                  2 y                  Bone                    Maxillary sinus,\                           Mass                                No         RTx                  NA
                                                                                                                                  nasal\                                                                                                          
                                                                                                                                  cavity                                                                                                          

  Kurisu         M/69          Nasal obstruction              NA                     NA                   NA                      Maxillary &\                                Mass                                No                              NA
                                                                                                                                  ethmoid sinuses, nasal\                                                                                         
                                                                                                                                  cavity                                                                                                          

  Liu            M/55          Epistaxis                      Hep B                  1 y                  Lung, mediantinum, LN   Vestibule, vault          1 w               Nasal cavity, maxillary bone\       No         Excisional biopsy    Brain mets, died, multiple metastatic disease (2 m)
                                                                                                                                                                              erosion                                                             

  Hwang          M/49          Epistaxis,\                    NA                     13 m                 Heel                    Septum, nasal\                              Mass                                Mass       Surgical resection   Aliver at\
                               nasal\                                                                                             cavity                                                                                                          8 m f/u
                               obstruction                                                                                                                                                                                                        

  Choi           M/45          Nasal mass                                            3 y                  Lung, abd LN            Vestibule                 1 y               Mass                                No         Chemo                Aliver at\
                                                                                                                                                                                                                                                  6 m f/u

  Izquierdo      M/59          Epistaxis,\                    Hep B, hep C           4 y                  Not mentioned           Maxillary sinus,\                           CT                                  No                              Died, hepatic failure during the hospitalization
                               nasal\                                                                                             nasal\                                                                                                          
                               obstruction                                                                                        cavity                                                                                                          

  Present case   M/53          Headache, nasal\               Hep B                  3 m                  Lung                    Nasal cavity              3 m               Osteolysis                          Mass       Excisional biopsy    Discharged, awaiting next chemoTx
                               obstruction                                                                                                                                                                                                        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abd, abdominal; Dx, diagnosis; f/u, follow-up; HCC, hepatocellular carcinoma; Hep, hepatitis; LN, lymph node; LT, liver transplantation; mets, metastasis; NA, not available; RTx, radiation therapy; Sx, symptoms; w, week; M, male; m, month; Tx, therapy; y, year

Case report {#s3}
===========

A 53-year-old male patient (hepatitis B carrier), who had been suffering for 3 months from HCC with multiple lung metastases, was admitted complaining of headache. A brain MRI scan that was performed to identify brain metastasis showed a solid mass occupying the left nasal cavity (3.7 × 1.8 × 2.8 cm). The mass showed iso-signal intensity on *T*~1~ weighted image, high signal intensity on *T*~2~ weighted image, and heterogeneous well enhancement on Gd-T~1~ weighted image ([Figure 1](#f1){ref-type="fig"}). Gradient-echo images showed small foci of low signal, suggesting haemorrhage in the mass. Restricted diffusion was not noted in the mass on diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) map. Metastasis of HCC was suggested, as the nasal cavity was normal on a positron emission tomography CT scan that had been performed 3 months ago. The patient had developed left nasal obstruction, clear rhinorrhea and left facial pain. A CT scan that was performed for excisional biopsy (17 days after the MRI scan) showed that the mass had rapidly increased in size (6.2 × 2.2 × 3.4 cm) with involvement of the ostium of the nasolacrimal duct and the lateral wall of the anterior nasal cavity ([Figure 2](#f2){ref-type="fig"}). There was no calcification in the mass on the pre-contrast CT scan. A punch biopsy was performed. Histological examination revealed tumour cells with enlarged nucleoli and clear cytoplasm arranged in trabecular cords and glandular arrays, consistent with metastatic HCC ([Figure 3](#f3){ref-type="fig"}). The tumour was grade 2 (moderately differentiated). While the patient was awaiting resection of the tumour, his general condition declined and he was transferred to another hospital owing to his location.

![(a--f) MRI scan shows a mass occupying the left nasal cavity. (a) Axial *T*~2~ weighted MRI scan shows heterogeneous high- signal-intensity mass compared with muscle. (b) Axial *T*~1~ weighted MRI scan shows heterogeneous iso-signal-intensity mass and multifocal high-signal foci that suggest a haemorrhagical component. (c). Axial gadolinium-enhanced *T*~1~ weighted MRI scan shows heterogeneous enhancement except for multifocal haemorrhagical foci. (d, e) Axial DWI and ADC MRI scan shows that the mass has no diffusion restriction (average ADC value = 1536.01 mm^2^ s^−1^). (f). Axial gradient-recalled echo MRI scan shows heterogeneous high-signal-intensity mass and multifocal haemorrhagic foci with dark signal intensity (arrow). ADC, apparent diffusion coefficient; DWI, diffusion-weighted imaging.](bjrcr.20160111.g001){#f1}

![a--c. CT scan shows a mass occupying the left nasal cavity. (a) Axial noncontrast CT scan shows the iso-attenuating mass compared with muscle and no calcification. (b) Axial contrast-enhanced CT scan shows the mass is heterogeneously enhancing. (c) Coronal contrast-enhanced CT scan shows the mass occupying the left nasal cavity. The lateral wall of the maxillary sinus is osteolysed.](bjrcr.20160111.g002){#f2}

![Pathological finding of the biopsy specimen from the left nasal cavity mass. Neoplastic polygonal cells are arranged in thick trabecular patterns, consistent with metastasis of hepatocellular carcinoma (hematoxylin and eosin stain; 200× magnification).](bjrcr.20160111.g003){#f3}

Discussion {#s4}
==========

HCC is the most common primary tumour of the liver, and its treatment depends entirely on the tumour stage and hepatocellular reserves.^[@r3]^ Knowledge of the location and radiographical appearance of metastatic HCC is therefore important for accurate tumour staging, to assure the patient the most appropriate treatment and best chance for survival. Because of rarity and lack of distinguishing features, metastasis of malignant neoplasms to the sinonasal region is often mistaken for primary neoplasm of the sinonasal tract.^[@r7]^ The kidney is the most common primary site, but other sources include the lung, breast, urogenital tract, gastrointestinal tract and thyroid gland.^[@r1],[@r2]^ HCC easily metastasizes, and extrahepatic metastasis occurs in more than 50% of HCC patients, with the most common metastatic sites being the lungs, abdominal lymph nodes, bone and adrenal glands.^[@r3]--[@r5]^ Metastasis of HCC to the sinonasal region, however, is uncommon and metastasis to the nasal cavity is exceedingly rare, with only 13 cases reported in the literature ([Table 1](#t1){ref-type="table"}). Among them, eight patients had metastatic HCC involving the paranasal sinus and extending into the nasal cavity (the maxillary sinus in three cases, the ethmoid sinus in one case, and the maxillary and ethmoid sinuses in one case); five patients had involvement of the nasal septum or nasal vestibule; and three patients had involvement of only the nasal cavity. As CT scan is the primary choice for imaging study of the head and neck region, MRI scan of these lesions was performed in only one case.^[@r8]^ We present an additional case of rapidly growing metastatic HCC to the nasal cavity with MRI scan.

HCC metastasizes by either lymphogenous or haematogenous spread.^[@r9]^ It is frequently noted to invade the local vascular network by direct extension into the caval venous system.^[@r10]^ Haematogenous spread through the systemic circulation is thus readily explainable. Once the tumour emboli enter the vascular system, they can flow through the pulmonary circulation and reach the sinonasal area through the arterial system of the head and neck.^[@r1],[@r2],[@r11]^ Including our case, more than half of reported cases of metastatic HCC to the nasal cavity had lung metastasis at presentation. If there is no evidence of lung metastasis, it has been postulated that the disease can spread through Batson's paraspinal venous plexus is a valveless venous system in the prevertebral, vertebral and epidural space.^[@r2]^ Without valves, the venous plexuses do not resist the spread of tumour emboli (especially during increase of intra-abdominal or intrathoracic pressure)^[@r13]^ and allow metatastic emboli to bypass to the pulmonary venous system, giving rise to metastasis to the head and neck region without involvement of the lungs.^[@r2],[@r13]^ The lymphatic system provides another route of spread. Tumour emboli from the regional lymph nodes can flow into the thoracic duct. In such cases, invasion of the hepatic, peripancreatic, celiac and para-aortic lymph nodes would be expected before the disease would spread into the head and neck.^[@r14]^ Metastases can reach the head and neck via retrograde flow through the intercostal, mediastinal or supraclavicular lymph vessels.^[@r15]^ In our case, because there was no metastatic lymphadenopathy but lung metastases were present, lymphatic spread seems more likely than haematogenous spread.

Metastatic tumours to the sinonasal cavity have no distinctive clinical features that may facilitate their early diagnosis. Epistaxis, facial deformity, pain and nasal obstructions are the common presenting symptoms, which are identical to those produced by primary tumours in the same area.^[@r1],[@r1],[@r16]^ Recurrent profuse epistaxis appears to be specific to haemangiomas and certain metastatic tumours, including renal cell carcinoma and melanoma.^[@r17]^ Frequent nasal bleeding from these metastatic tumours are known to be associated with their hypervascularity. In addition to these tumours, metastatic HCC might be a candidate for recurrent profuse epistaxis owing to the high vascularity of the tumour as well as coagulopathy owing to underlying liver cirrhosis.^[@r18]^ The present patient, however, had no sinonasal symptoms when he was referred for headache and the nasal cavity mass was incidentally found on brain MRI scan. Nasal obstruction, facial pain and rhinorrhea had developed during follow-up as the size of the mass rapidly increased. Thus, as in the present case, the only clue of metastasis might be a history of a primary tumour elsewhere.

In this case, the metastatic HCC showed high *T*~2~ signal intensity with no restricted diffusion on DWI. Virtually all sinonasal tumours are highly cellular, with relatively little intracellular and intercellular water.^[@r19]^ As a result, the majority of these tumours have intermediate signal intensity on *T*~2~ weighted images.^[@r19]^ It is rare for sinonasal malignant tumours to have inherently high *T*~2~ weighted signal intensity. Such high *T*~2~ weighted signal intensity may occur with benign or low-grade minor salivary gland tumours, schwannomas, haemangiomas and polypoid tumours such as inverted papillomas.^[@r20]^ Technically feasible in the head and neck regions, the addition of DWI increases detection of malignant lesion and is useful for differentiating both solid from cystic lesions and benign from malignant lesions.^[@r21]^ Mostly, malignant lesions have lower ADC values compared with benign lesions. In a retrospective study of 33 patients with 17 benign and 16 malignant head and neck lesions, an optimal ADC threshold of 1.3 × 10^−3 ^mm^2^ s^−1^ was established for diagnosis of malignant tumours from benign lesions.^[@r22]^ In the present patient, the mass showed high signal intensity with intermediate signal foci on *T*~2~ weighted images and restricted diffusion of the tumour was not apparent (average ADC value 1536.01 mm^2^ s^−1^) on DWI. This finding probably related to the differentiation of the metastatic HCC, as it is known that histopathological differentiation of HCC is inversely correlated with the ADC value.^[@r23]^ The metastatic HCC presented here was moderately differentiated. This suggested that metastatic HCC may have varying *T*~2~ signal intensity with a wide range of ADC values, and may mimic benign tumours in the nasal cavity. Further investigation should be performed with a larger case series.

Metastasis to the nasal cavity is usually associated with advanced disease and early mortality. As most extrahepatic HCC occurs in patients with an advanced intrahepatic stage of tumour,^[@r3]^ metastasis to the sinonasal region is also associated with advanced disease and early mortality.^[@r3],[@r24],[@r25]^ The mean survival time of patients is reported to range from 4 weeks to 26 months after the identification of sinonasal metastasis.^[@r18],[@r26],[@r27]^ In our review of the literature,^[@r6]--[@r8],[@r16],[@r26]--[@r32]^ most patients were dead less than 2 months after diagnosis of the nasal cavity metastasis. Three of 13 reported patients died of terminal hepatic failure, one of sudden respiratory failure and one of multiple metastases; the remaining four cases were in the following 8 to 15 months. Various treatments for metastatic HCC to the sinonasal cavity have been reported, including surgical resection, palliative radiotherapy and transcatheter arterial embolisation to control nasal bleeding. The treatment should be selected on an individual basis and the purpose of treatment.^[@r8],[@r27],[@r32]^

Conclusions {#s5}
===========

In conclusion, although metastatic HCC to the nasal cavity is rare and the imaging findings are rather nonspecific, clinicians and radiologists should be aware of this unusual presentation because of its poor prognosis and the possibility of rapid deterioration in the setting of underlying HCC. We present a rare case of metastatic HCC to the nasal cavity with MRI scan including DWI.

Learning points {#s6}
===============

1.  Metastasis to the nasal cavity of HCC is extremely rare. But when it occurs, it usually associated with advanced disease and early mortality.

2.  Most of sinonasal malignant tumours are highly cellular, with relatively little intracellular and intercellular water, so they have intermediate signal intensity on *T*~2~ weighted image and have lower ADC values compared with benign tumours.

3.  But, even sinonasal metastatic cancer of HCC has high signal intensity on *T*~2~ weighted images, and restricted diffusion of the tumour was not apparent on DWI depending on histopathological differentiation.

Consent {#s7}
=======

Written informed consent for the case to be published (includingimages, case history and data) was obtained from the patient(s) for publication of this case report, including accompanying images.
